Professor Roy Taylor joins Lauren Southwell to talk about his Review discussing the causes of type 2 diabetes.The Lancet tarafından oluşturuldu

Professor Ponnusamy Saravanan, Dr Uma Ram, and Dr Kosgei Wycliffe join Lauren Southwell to discuss STRiDE, a prospective cohort study in India and Kenya, and the multi-ethnic PRiDE cohort in the UK to assess early pregnancy HbA1c as a screening test for gestational diabetes.The Lancet tarafından oluşturuldu

Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.The Lancet tarafından oluşturuldu

Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective.The Lancet tarafından oluşturuldu

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.The Lancet tarafından oluşturuldu

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.The Lancet tarafından oluşturuldu

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.The Lancet tarafından oluşturuldu

Margherita Pizzato talks with The Lancet Diabetes & Endocrinology about the global epidemiological landscape of thyroid cancer based on GLOBOCAN estimates in 2020.The Lancet tarafından oluşturuldu

Angela Titmuss talks with The Lancet Diabetes & Endocrinology about youth-onset type 2 diabetes among First Nations young people in northern Australia.The Lancet tarafından oluşturuldu

Sanjay Basu talks with The Lancet Diabetes & Endocrinology about what is an affordable price for newer type 2 diabetes medicines in low-income and middle-incomes countries.The Lancet tarafından oluşturuldu

Philip Home talks with The Lancet Diabetes & Endocrinology about the insulin centenary and how insulin therapy might develop in the future.The Lancet tarafından oluşturuldu

Victoria Salem talks with The Lancet Diabetes & Endocrinology about how to improve female inclusion and participation in scientific medical conferences.The Lancet tarafından oluşturuldu

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.The Lancet tarafından oluşturuldu

Rishi Caleyachetty talks with The Lancet Diabetes & Endocrinology about the need to revise ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk.The Lancet tarafından oluşturuldu

Thomas Robinson talks with The Lancet Diabetes & Endocrinology about the Stanford GOALS randomised controlled trial in Latinx children with overweight or obesity.The Lancet tarafından oluşturuldu

Adrian Martineau talks with The Lancet Diabetes & Endocrinology about how vitamin D supplementation can reduce the risk of acute respiratory infections.The Lancet tarafından oluşturuldu

William Kraus talks with The Lancet Diabetes & Endocrinology about how calorie restriction can reduce cardiometabolic risk even in young, healthy, non-obese adults.The Lancet tarafından oluşturuldu

Hiddo Lambers Heerspink talks with The Lancet Diabetes & Endocrinology about his work on changes in albuminuria and subsequent effect on kidney disease.The Lancet tarafından oluşturuldu

Mark Atkinson and Bart Roep join The Lancet Diabetes & Endocrinology to discuss a new Series on immune-based therapies for type 1 diabetes.The Lancet tarafından oluşturuldu

Series authors Annewieke van den Beld, Bu Yeap, Robin Peeters, and Zaki Hassan-Smith discuss how the endocrine system changes with age and the implications for healthy ageing.The Lancet tarafından oluşturuldu

Mohammed Ali talks to The Lancet Diabetes & Endocrinology about the cardiovascular and renal burdens of prediabetes in the USA.The Lancet tarafından oluşturuldu

Richard Oram discusses a study which uses UK Biobank data to look at the frequency of type 1 diabetes across the first six decades of life.The Lancet tarafından oluşturuldu

Michael Zimmerman talks about the effect of iodine supplementation in pregnant women on child development.The Lancet tarafından oluşturuldu

Moffat Nyirenda talks about the challenges facing diabetes in sub-Saharan Africa, as highlighted in a new Commission.The Lancet tarafından oluşturuldu

Martin Reincke discusses outcomes after adrenalectomy for unilateral primary aldosteronism.The Lancet tarafından oluşturuldu

Two authors of papers on bariatric surgery in adolescents, Thomas Inge and Torsten Olbers, discuss their work, published in The Lancet Diabetes and Endocrinology.The Lancet tarafından oluşturuldu

Professor Mark Hanson, Director of the Institute of Developmental Sciences at the University of Southampton, discusses the society and policy changes needed to tackle the growing epidemic of maternal obesity worldwide.The Lancet tarafından oluşturuldu

Professor Paul Little talks about the PoWER+ trial, a system aimed at cost-effective, internet-based support for weight loss.The Lancet tarafından oluşturuldu

Dr Francesco Zaccardi discusses an article about hospital admissions for hypoglycaemia in England from 2005 to 2015.The Lancet tarafından oluşturuldu

Dr. Justin White discusses neighbourhood effects and how to research themThe Lancet tarafından oluşturuldu

Ellen Flint and Caroline Brogan discuss the effect of active commuting on BMI and obesity.The Lancet tarafından oluşturuldu

David Beran discusses the challenges faced around the world to accessing insulin.The Lancet tarafından oluşturuldu

Barry Popkin discusses how public health measures globally need to address sugar content in beverages and food.The Lancet tarafından oluşturuldu

Lucilla Poston discusses results of the UPBEAT trial, which tested whether an intensive lifestyle intervention in obese women during pregnancy can reduce the incidence of gestational diabetes and large-for-gestational-age babies.The Lancet tarafından oluşturuldu

How do different methods for diagnosing diabetes affect estimates of prevalence and how is this likely to affect global estimates of this disease?The Lancet tarafından oluşturuldu

Does smoking cessation affect glycaemic control in people with diabetes?The Lancet tarafından oluşturuldu

Alexandra Papaioannou and John Schousboe discuss the pros and cons of expanding diagnostic criteria for osteoporosis.The Lancet tarafından oluşturuldu

Dick de Zeeuw discusses a trial looking at the effect of statins on renal function.The Lancet tarafından oluşturuldu

Lawrence Phillips talks about a study looking at the effects of a lifestyle programme on diabetes incidence and weight loss in a real-world population in the USA.The Lancet tarafından oluşturuldu

Edward Gregg from the US Centers for Disease Control discusses the rise in US diabetes incidence, and a concurrent fall in mortality from diabetes.The Lancet tarafından oluşturuldu

John Deanfield discusses lifetime changes in BMI and cardiovascular risk.The Lancet tarafından oluşturuldu

John Wentworth and Paul O'Brien discuss a randomized trial of bariatric surgery for overweight, non-obese people with type 2 diabetes.The Lancet tarafından oluşturuldu

Dr Rowan Gillies joins Natalie Harrison to discuss surgery for people with diabetes in low-income and middle-income countries.The Lancet tarafından oluşturuldu

Norbert Stefan discusses a small but positive trial of a new drug in people with non-alcoholic fatty liver disease.The Lancet tarafından oluşturuldu

Mark Bolland discusses the results of a sequential trial meta-analysis of the effects of vitamin D supplementation on skeletal, vascular, and cancer outcomes.The Lancet tarafından oluşturuldu

Michael Nauck discusses incretin-based drugs and pancreatitis risk.The Lancet tarafından oluşturuldu

Ambady Ramachandran discusses using text messaging to prevent diabetes in men at high risk of developing the disease.The Lancet tarafından oluşturuldu

Rachel Whitmer discusses a dementia risk score for people with type 2 diabetes.The Lancet tarafından oluşturuldu

Anna Peeters discusses diabetes and risk of physical disability in adults.The Lancet tarafından oluşturuldu

Deputy Editor Sarah Allan discusses the contents of a special preview of The Lancet Diabetes & Endocrinology, as well as plans for the journal's launch in September.The Lancet tarafından oluşturuldu